Skip to content

HLA Fusion clinical trial

HLA Fusion

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900028696
Enrollment
Unknown
Registered
2019-12-31
Start date
2020-02-01
Completion date
Unknown
Last updated
2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

For One Lambda product analysis (typing and antibody testing)

Interventions

Gold Standard:In clinical practice, the results are usually interpreted manually by doctors.
results&#32
by&#32
software.

Sponsors

The first affiliated hospital of medical college of zhejiang university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Test data obtained by each clinical trial unit, including data obtained by routine clinical diagnosis and treatment of clinical trial institutions, or data obtained by four tests (LABType,Micro SSP,LABScreen and LAT) using residual blood samples of institutions; 2. Data format meets the requirements of software reading; 3. The samples corresponding to all test data should have corresponding basic clinical information, including sample number, gender, age and clinical diagnosis.

Exclusion criteria

Exclusion criteria: 1. Samples with incomplete relevant information; 2. Duplicate samples of the same patient in the same module.

Design outcomes

Primary

MeasureTime frame
Consistency analysis;

Secondary

MeasureTime frame
Software performance evaluation;

Countries

China

Contacts

Public ContactLU XIAOJUN

Molecular Diagnostic Laboratory of Experimental Medicine, West China Hospital, Sichuan University

luxiaojun1972@163.com+86 189 8060 2271

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026